BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 18990129)

  • 1. Prospects of cell therapy for disorders of myelin.
    Ben-Hur T; Goldman SA
    Ann N Y Acad Sci; 2008 Oct; 1142():218-49. PubMed ID: 18990129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remyelination of the central nervous system: a valuable contribution from the periphery.
    Zujovic V; Bachelin C; Baron-Van Evercooren A
    Neuroscientist; 2007 Aug; 13(4):383-91. PubMed ID: 17644768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of pathogenesis in multiple sclerosis: implications for promotion of remyelination.
    Paz Soldan MM; Rodriguez M
    J Infect Dis; 2002 Dec; 186 Suppl 2():S248-53. PubMed ID: 12424705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular approaches to central nervous system remyelination stimulation: thyroid hormone to promote myelin repair via endogenous stem and precursor cells.
    Calzà L; Fernandez M; Giardino L
    J Mol Endocrinol; 2010 Jan; 44(1):13-23. PubMed ID: 19578096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cellular and molecular events of central nervous system remyelination.
    Dubois-Dalcq M; Armstrong R
    Bioessays; 1990 Dec; 12(12):569-76. PubMed ID: 2080911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Candidate cells for remyelinating of the central nervous system].
    Nait Oumesmar B; Lachapelle F; Decker L; Avellana-Adalid V; Vitry S; Baron-Van Evercooren A
    Rev Neurol (Paris); 1998 Sep; 154(8-9):592-9. PubMed ID: 9809374
    [No Abstract]   [Full Text] [Related]  

  • 7. Cellular approaches for stimulating CNS remyelination.
    Miller RH; Bai L
    Regen Med; 2007 Sep; 2(5):817-29. PubMed ID: 17907933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cells of the oligodendroglial lineage, myelination, and remyelination.
    Miron VE; Kuhlmann T; Antel JP
    Biochim Biophys Acta; 2011 Feb; 1812(2):184-93. PubMed ID: 20887785
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remyelination in demyelinating disease.
    Scolding NJ; Franklin RJ
    Baillieres Clin Neurol; 1997 Oct; 6(3):525-48. PubMed ID: 10101588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glial progenitor-based repair of demyelinating neurological diseases.
    Keyoung HM; Goldman SA
    Neurosurg Clin N Am; 2007 Jan; 18(1):93-104, x. PubMed ID: 17244557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stem cell-based strategies for treating pediatric disorders of myelin.
    Goldman SA; Schanz S; Windrem MS
    Hum Mol Genet; 2008 Apr; 17(R1):R76-83. PubMed ID: 18632701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signalling pathways that inhibit the capacity of precursor cells for myelin repair.
    Sabo JK; Cate HS
    Int J Mol Sci; 2013 Jan; 14(1):1031-49. PubMed ID: 23296277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelin regeneration in demyelinating disorders: new developments in biology and clinical pathology.
    Zawadzka M; Franklin RJ
    Curr Opin Neurol; 2007 Jun; 20(3):294-8. PubMed ID: 17495623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repair of myelin disease: strategies and progress in animal models.
    Duncan ID; Grever WE; Zhang SC
    Mol Med Today; 1997 Dec; 3(12):554-61. PubMed ID: 9449127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancing central nervous system remyelination in multiple sclerosis.
    Dubois-Dalcq M; Ffrench-Constant C; Franklin RJ
    Neuron; 2005 Oct; 48(1):9-12. PubMed ID: 16202704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The therapeutic use of stem cells for myelin repair in autoimmune demyelinating disorders.
    Pluchino S; Martino G
    J Neurol Sci; 2005 Jun; 233(1-2):117-9. PubMed ID: 15896808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic strategies in multiple sclerosis. II. Long-term repair.
    Scolding N
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1711-20. PubMed ID: 10603622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of demyelination and remyelination.
    Ludwin SK
    Adv Neurol; 1981; 31():123-68. PubMed ID: 7325040
    [No Abstract]   [Full Text] [Related]  

  • 19. [Regenerative capacity in multiple sclerosis].
    Lubetzki C
    Bull Acad Natl Med; 2008 Mar; 192(3):495-504; discussion 505-6. PubMed ID: 18819695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and remyelination in the central nervous system: a tale of two systems.
    Ruffini F; Kennedy TE; Antel JP
    Am J Pathol; 2004 May; 164(5):1519-22. PubMed ID: 15111297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.